NASDAQ:JSPR | Free Cash Flow | Jasper Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$14.55M
2025-12-31-$21.87M
2025-03-31-$22.84M
2024-12-31-$21.13M
2024-03-31-$15.74M
2023-12-31-$16.48M
2023-03-31-$10.34M
2022-12-31-$12.65M
2022-03-31-$14.21M
2021-12-31-$14.58M
2021-03-31-$6.2M
2020-12-31-$5.39M
2020-03-31-$232,870.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$77.16M
2024-12-31-$62.6M
2023-12-31-$52.07M
2022-12-31-$45.86M
2021-12-31-$33.68M
2020-12-31-$18.27M